Overview: Issues in young children and adults

Teiji Tominaga; Miki Fujimura

doi:10.1007/978-4-431-99703-0_40

Overview: Issues in young children and adults

Teiji Tominaga, Miki Fujimura

MED - Medical Sciences

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Moyamoya disease is a chronic, occlusive cerebrovascular disease with unknown etiology which has two peaks in age distribution, a first peak in children and the second peak in young adults [1]. The most recent epidemiological national survey in Japan estimates that the annual number of the patients with moyamoya disease is 7,700 with the incidence rate of 5.4 per million populations, with the female/male ratio of 1.8:1 [2]. The peaks in age distribution of moyamoya disease consist of a first peak in children and the second peak in young adults. The incidence of patients with family history was 12.1% among definitive moyamoya patients [2]. In this chapter, the authors seek to overview the characteristics of moyamoya disease in children and young adults.

Original language	English
Title of host publication	Moyamoya Disease Update
Publisher	Springer Japan
Pages	287-293
Number of pages	7
ISBN (Print)	9784431997023
DOIs	https://doi.org/10.1007/978-4-431-99703-0_40
Publication status	Published - 2010

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-4-431-99703-0_40

Fingerprint Dive into the research topics of 'Overview: Issues in young children and adults'. Together they form a unique fingerprint.

Cite this

@inbook{b8aa71f57b2a491e92214d6a16732bb6,

title = "Overview: Issues in young children and adults",

abstract = "Moyamoya disease is a chronic, occlusive cerebrovascular disease with unknown etiology which has two peaks in age distribution, a first peak in children and the second peak in young adults [1]. The most recent epidemiological national survey in Japan estimates that the annual number of the patients with moyamoya disease is 7,700 with the incidence rate of 5.4 per million populations, with the female/male ratio of 1.8:1 [2]. The peaks in age distribution of moyamoya disease consist of a first peak in children and the second peak in young adults. The incidence of patients with family history was 12.1% among definitive moyamoya patients [2]. In this chapter, the authors seek to overview the characteristics of moyamoya disease in children and young adults.",

author = "Teiji Tominaga and Miki Fujimura",

year = "2010",

doi = "10.1007/978-4-431-99703-0_40",

language = "English",

isbn = "9784431997023",

pages = "287--293",

booktitle = "Moyamoya Disease Update",

publisher = "Springer Japan",

}

TY - CHAP

T1 - Overview

T2 - Issues in young children and adults

AU - Tominaga, Teiji

AU - Fujimura, Miki

PY - 2010

Y1 - 2010

N2 - Moyamoya disease is a chronic, occlusive cerebrovascular disease with unknown etiology which has two peaks in age distribution, a first peak in children and the second peak in young adults [1]. The most recent epidemiological national survey in Japan estimates that the annual number of the patients with moyamoya disease is 7,700 with the incidence rate of 5.4 per million populations, with the female/male ratio of 1.8:1 [2]. The peaks in age distribution of moyamoya disease consist of a first peak in children and the second peak in young adults. The incidence of patients with family history was 12.1% among definitive moyamoya patients [2]. In this chapter, the authors seek to overview the characteristics of moyamoya disease in children and young adults.

AB - Moyamoya disease is a chronic, occlusive cerebrovascular disease with unknown etiology which has two peaks in age distribution, a first peak in children and the second peak in young adults [1]. The most recent epidemiological national survey in Japan estimates that the annual number of the patients with moyamoya disease is 7,700 with the incidence rate of 5.4 per million populations, with the female/male ratio of 1.8:1 [2]. The peaks in age distribution of moyamoya disease consist of a first peak in children and the second peak in young adults. The incidence of patients with family history was 12.1% among definitive moyamoya patients [2]. In this chapter, the authors seek to overview the characteristics of moyamoya disease in children and young adults.

UR - http://www.scopus.com/inward/record.url?scp=84895261363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895261363&partnerID=8YFLogxK

U2 - 10.1007/978-4-431-99703-0_40

DO - 10.1007/978-4-431-99703-0_40

M3 - Chapter

AN - SCOPUS:84895261363

SN - 9784431997023

SP - 287

EP - 293

BT - Moyamoya Disease Update

PB - Springer Japan

ER -